# Extraction Matrix Shapes the Efficacy of Gegen Qinlian Decoction in DSS-Induced Colitis: A Preclinical Systematic Review and Meta-Analysis

**Authors:** Carlos R. Montes-de-Oca-Saucedo, Bruno Briceño-Villardaga, Sebastián R. Fuentes-Salinas, Adolfo Soto-Domínguez

PMC · DOI: 10.3390/ph19020277 · Pharmaceuticals · 2026-02-06

## TL;DR

This study finds that the extraction method of a traditional Chinese medicine, Gegen Qinlian Decoction, affects its effectiveness in treating colitis in mice.

## Contribution

The study systematically compares the efficacy of aqueous versus ethanolic extractions of GQD in preclinical colitis models.

## Key findings

- Aqueous GQD showed consistent improvement in disease activity and colon length with low heterogeneity.
- Ethanolic GQD had variable results despite a larger effect on histology.
- Aqueous GQD reduced inflammation and improved gut microbiota diversity.

## Abstract

Background: Ulcerative colitis (UC) is a chronic inflammatory disease marked by mucosal injury and immune dysregulation. Gegen Qinlian Decoction (GQD) shows therapeutic potential, but extraction-dependent reproducibility remains unclear. Methods: We systematically searched PubMed, Scopus, and Web of Science for studies evaluating GQD aqueous decoctions or ethanolic extracts in DSS-induced colitis. Main outcome: Disease Activity Index (DAI). Key additional outcomes: colon length and histological injury; cytokines and microbiota were also assessed. Random-effects models with Hartung–Knapp–Sidik–Jonkman adjustment, subgroup analyses, and exploratory dose–response meta-regression were applied. Results: Eight studies were included (aqueous: 5; ethanolic: 3; 209 mice). GQD significantly improved DAI (SMD −2.17; p < 0.00001; I2 = 43%), colon length (MD 1.18 cm; p < 0.00001; I2 = 88%), and histological injury (SMD −3.02; p < 0.0001; I2 = 51%). For DAI, both preparations favored GQD, with absent heterogeneity in aqueous studies (I2 = 0%) vs. substantial variability in ethanolic extracts (I2 = 75%). For histology, subgroup differences suggested a larger effect size with ethanolic extracts, with higher heterogeneity (I2 = 60% vs. 0%). In the aqueous subset, GQD reduced inflammatory markers and increased microbial diversity. Dose–response meta-regression was performed within the aqueous subset as an exploratory analysis. Conclusions: Aqueous decoctions showed the most reproducible profile across key endpoints, whereas ethanolic extracts were more variable despite a larger histology point estimate, indicating that the extraction matrix meaningfully influences translational consistency in preclinical research.

## Linked entities

- **Diseases:** Ulcerative colitis (MONDO:0005101)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Mpo (myeloperoxidase) [NCBI Gene 17523] {aka mKIAA4033}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Atoh1 (atonal bHLH transcription factor 1) [NCBI Gene 11921] {aka Hath1, MATH-1, Math1, bHLHa14}, Muc2 (mucin 2) [NCBI Gene 17831] {aka 2010015E03Rik, MCM, wnn}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Foxp3 (forkhead box P3) [NCBI Gene 20371] {aka JM2, scurfin, sf}, Hes1 (hes family bHLH transcription factor 1) [NCBI Gene 15205] {aka Hry, bHLHb39}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Cd163 (CD163 antigen) [NCBI Gene 93671] {aka CD163v2, CD163v3}, Jak2 (Janus kinase 2) [NCBI Gene 16452] {aka Fd17}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Bax (BCL2-associated X protein) [NCBI Gene 12028], Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 26419] {aka JNK, JNK1, Prkm8, SAPK1}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Cdh1 (cadherin 1) [NCBI Gene 12550] {aka ARC-1, E-cad, Ecad, L-CAM, UVO, Um}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Il2ra (interleukin 2 receptor, alpha chain) [NCBI Gene 16184] {aka CD25, Il2r, Ly-43}, Rbpj (recombination signal binding protein for immunoglobulin kappa J region) [NCBI Gene 19664] {aka CBF1, Igkjrb, Igkrsbp, RBP-J, RBP-J kappa, RBP-Jkappa}, Slc7a11 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 11) [NCBI Gene 26570] {aka 9930009M05Rik, sut, xCT}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Cldn2 (claudin 2) [NCBI Gene 12738], Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}
- **Diseases:** SYRCLE (MESH:D007757), epithelial injury (MESH:D009375), DAI (MESH:C566784), weight loss (MESH:D015431), DSS (MESH:C562576), Colitis (MESH:D003092), gastrointestinal syndromes (MESH:D005767), IBD (MESH:D015212), mucosal injury (MESH:D052016), UC (MESH:D003093), colon shortening (MESH:D003108), immune dysregulation (OMIM:614878), inflammation (MESH:D007249), injury to (MESH:D014947), Febrile Diseases (MESH:D004194), edema (MESH:D004487), abdominal pain (MESH:D015746), rectal bleeding (MESH:D012002), bloody diarrhea (MESH:D003967), fever (MESH:D005334)
- **Chemicals:** NO (MESH:D009614), puerarin (MESH:C033607), Ethanolic (-), arginine (MESH:D001120), CH223191 (MESH:C511621), LPS (MESH:D008070), steroid (MESH:D013256), GSH (MESH:D005978), DSS (MESH:D016264), Periodic acid (MESH:D010504), berberine (MESH:D001599), baicalin (MESH:C038044), flavonoids (MESH:D005419), T0070907 (MESH:C458508), tryptophan (MESH:D014364), oxygen (MESH:D010100), nitrate (MESH:D009566), mesalazine (MESH:D019804), proline (MESH:D011392), MDA (MESH:D015104), lactate (MESH:D019344), polysaccharide (MESH:D011134), wogonoside (MESH:C473995), luminal (MESH:D010634), Alcian blue (MESH:D000423), Ethanol (MESH:D000431), alkaloids (MESH:D000470), branched-chain amino acid (MESH:D000597)
- **Species:** Glycyrrhiza uralensis (Chinese licorice, species) [taxon 74613], Homo sapiens (human, species) [taxon 9606], Bacteroides (genus) [taxon 816], Pueraria montana var. lobata (kudzu, varietas) [taxon 3893], Akkermansia (genus) [taxon 239934], Escherichia coli (E. coli, species) [taxon 562], Coptis chinensis (species) [taxon 261450], Lactobacillus (genus) [taxon 1578], Scutellaria baicalensis (Baikal skullcap, species) [taxon 65409], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943224/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943224/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943224/full.md

---
Source: https://tomesphere.com/paper/PMC12943224